Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring syst… Read more
Iradimed Co (IRMD) - Total Liabilities
Latest total liabilities as of December 2025: $14.16 Million USD
Based on the latest financial reports, Iradimed Co (IRMD) has total liabilities worth $14.16 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Iradimed Co - Total Liabilities Trend (2012–2025)
This chart illustrates how Iradimed Co's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Iradimed Co Competitors by Total Liabilities
The table below lists competitors of Iradimed Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Five-Star Business Finance Limited
NSE:FIVESTAR
|
India | ₹86.28 Billion |
|
BrightView Holdings
NYSE:BV
|
USA | $1.55 Billion |
|
Com7 Public Company Limited
BK:COM7-R
|
Thailand | ฿16.52 Billion |
|
Pan Ocean Co Ltd
KO:028670
|
Korea | ₩5.01 Trillion |
|
Insperity Inc
NYSE:NSP
|
USA | $2.16 Billion |
|
Nippon Gas Co., Ltd.
PINK:NPNGY
|
USA | $74.23 Billion |
|
Limbach Holdings Inc
NASDAQ:LMB
|
USA | $185.47 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Iradimed Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Iradimed Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Iradimed Co (2012–2025)
The table below shows the annual total liabilities of Iradimed Co from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $14.16 Million | +23.04% |
| 2024-12-31 | $11.51 Million | -44.51% |
| 2023-12-31 | $20.74 Million | +75.12% |
| 2022-12-31 | $11.84 Million | +10.58% |
| 2021-12-31 | $10.71 Million | +10.59% |
| 2020-12-31 | $9.68 Million | -13.59% |
| 2019-12-31 | $11.20 Million | +72.47% |
| 2018-12-31 | $6.50 Million | +6.82% |
| 2017-12-31 | $6.08 Million | +14.63% |
| 2016-12-31 | $5.31 Million | +60.23% |
| 2015-12-31 | $3.31 Million | +36.88% |
| 2014-12-31 | $2.42 Million | +54.66% |
| 2013-12-31 | $1.56 Million | -32.99% |
| 2012-12-31 | $2.33 Million | -- |